SUMMARY. Strains of group-G streptococci were tested by a "fingerprinting" method for the production of (P typing) and sensitivity to (S typing) inhibitory agents, and were biotyped. In the standard P-typing test, 28 of 50 strains of human origin, but none of 30 strains of animal origin, showed inhibitory activity. Of the human strains, 12 formed a bacteriocin that was active on group-A streptococci, including three (strains 12, I5 and 18) of the four streptococci of this group among the indicator strains. Sixteen other human strains inhibited the fourth group-A indicator (strain I7), and to a lesser extent strain 12, by lowering the pH of the typing medium. This acid-mediated inhibition was eliminated by testing on a medium containing calcium carbonate 0.5%; the 16 strains were then completely non-inhibitory, and the bacteriocinforming strains, the typing pattern of which had originally been 12,15, 17, 18, showed only inhibition attributable to the action of the bacteriocin. Nearly all group-A streptococci were sensitive to the group-G bacteriocin. The indicator strain I7 and several other members of M-type 28 were exceptions, but their resistance was not associated with the presence of R-antigen 28. Fifteen inhibitor-sensitivity patterns and 12 biotypes were identified among the strains; some of these tended to be associated with either a human or an animal origin. Neither S type nor biotype appeared to correlate with inhibitor production.
INTRODUCTION
Group-G streptococci have long been recognised as significant causes of acute infections in dogs (Biberstein, Brown and Smith, 1980) , cats (Bosworth, Ewert and Bray, 1973) and cattle (Bergner-Rabinowitz et al., 198 1). More recently they have also been singled out for special comment as apparent causes of a variety of acute human infections (Blair and Martin, 1978; Bouza, Meyer and Busch, 1978; Appelbaum et al., 1980; Tuazon, 1980) . The question arises of the closeness of the relationship between group-G streptococci isolated from various hosts, including man.
Organisms classified as group-G streptococci occur as either minute or largecolony strains. Most clinical isolates are of the large-colony form, of which there appear to be at least three distinct serotypes (Simmons and Keogh, 1940) . Several biotypes based on the .fermentation of lactose, trehalose and sorbitol have been described among group-G streptococci of canine origin (Biberstein et al., 1980) . In a previous study in which an inhibitor-"fingerprinting" scheme was used, P (producer) typing of 16 human strains of group-G streptococci showed that seven were of P-type 226 and three of P-type 004 (Tagg and Bannister, 1979) . One of the P-type 226 streptoeocci (strain W2580) was included as strain P4 in the set of nine inhibitorproducing strains used in the S (sensitivity)-typing component of the "fingerprinting" scheme. The inhibitor released by strain W2580 was heat labile and non-dialysable and its production was dependent upon the presence of a heat-labile blood component in the typing medium. Subsequently, it was concluded that this inhibitor was probably a bacteriocin; it was a trypsin-sensitive substance of mol. wt c. 18 000, and with bactericidal activity against 96% of 350 strains of group-A streptococci (Wong, Tagg and Hynes, 198 1) .
MATERIALS AND METHODS
Bacterial strains. The 50 group-G streptococcus strains of human origin were isolated from epidemiologically unrelated clinical specimens and were provided by Dr L.W. Wannamaker. Six of these strains were from the West Indies and had been obtained from Dr Elizabeth Potter; they had been isolated from patients with acute glomerulonephritis. The remainder of the human strains were from patients in the USA. The animal strains comprised 21 from dogs (provided by Dr E.L. Biberstein, University of California), six from cats (provided by Dr J. Reitmeyer, University of Texas) and three from cattle (provided by Dr Sonya BergnerRabinowitz, Ministry of Health, Jerusalem). All the strains were shown to have the Lancefield group-G antigen by precipitation tests in capillary tubes with group-specific rabbit antisera. The nine indicator strains (11-19) used for P typing and the six inhibitor-producing strains (Pl-P6) used for S typing have been described previously (Tagg and Bannister, 1979) . Strains representative of recognised M types of group A streptococci included those listed previously (Tagg and Bannister, 1979) plus strains representative of M types 64-8 1 inclusive. All of these strains, as well as additional type-28 and type-1 strains, were provided by courtesy of Dr L.W. Wannamaker. Some of the latter strains have been described previously (Top and Wannamaker, 1968 ). Acid extracts were tested for R28 antigen by double diffusion in gel against R28-specific antiserum.
The procedure for inhibitor "fingerprinting" and for the recording of inhibition patterns in code form has been described elsewhere (Tagg and Bannister, 1979) . The basic P-typing procedure may be summarised as follows. The typing medium was Columbia Blood Agar Base (Difco) with human blood 5% (v/v), poured as a layer (20 ml) on a base of saline agar (20 ml) in glass petri dishes of diameter 9 cm. In some studies the top layer was supplemented with calcium carbonate 0.5% (w/v) to eliminate inhibition due to acid production. The test strains were propagated on blood agar. A l-cm-wide streak of the potential inhibitor-producing strain was inoculated across the diameter of the surface of the typing medium by means of a cotton swab and the plate was incubated at 32°C for 18 h. The visible growth was then removed by scraping with the edge of a glass slide and the plate inverted for 30 min over a circle of chloroform-soaked filter paper in the lid of the petri dish. After the surface of the plate had been exposed to the air for 15 min, Todd-Hewitt broth (Difco) cultures of the indicator strains were streaked with cotton swabs at right angles to the line of the growth of the producer. After incubation at 32°C for 18 h, inhibition of growth of the indicator strains was recorded as + (definite inhibition), (+) (partial inhibition) or -(no inhibition). Strains giving (+) reactions were retested. The inhibition patterns were recorded in code form by considering the nine indicators as three triplets (11,12,13; 14,15,16; 17,18,19 against each indicator were given a score of 4, 2 or 1 depending on whether the indicator was respectively the first, second or third member of the triplet. Negative reactions were scored as zero. The total score for each triplet thus specified uniquely the reactions against the three indicators. The complete P-type code was written as a sequence of three numbers, consecutively defining the reactions within the three triplets. A similar procedure was adopted to record the sensitivity (S type) of the test strains to the standard producer strains (PI, P2, P3; P4, P5, P6) in the S-typing system. Recent studies (Schofield and Tagg, 1983; Tagg, unpublished observations) have shown that these are the most reliable of the nine original standard producer strains (Tagg and Bannister, 1979) used for S-typing. Biotyping. Fermentation tests were performed in Phenol Red Broth Base (BBL) supplemented with 0.1 ml of filter-sterilised, inactivated horse serum per 5 ml of medium and containing 1% (w/v) of lactose, salicin, inulin, trehalose or sorbitol. Cultures were examined for the production of an acid reaction for up to 4 days at 37°C. Aesculin hydrolysis was detected by the addition of ferric citrate to cultures in Brain Heart Infusion Broth (Difco) plus aesculin 0.1% after incubation for 4 days at 37°C.
Surface pH of medium was measured by a Model 9210 combination surface pH electrode (Broadley James Corp., Santa Anna, CA).
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RESULTS
P typing of group-G streptococci in the usual inhibitor "fingerprinting" conditions gave four P-type reactions (Table I ). All 30 of the animal strains and 22 of the 50 human strains were of P-type 000 (not inhibitory to any of the nine indicators). Nine human strains were of P-type 004 (inhibitory to indicator 17) and seven of P-type 204 (inhibitory to strains I7 and 12). The 12 remaining human strains were of P-type 226 (active against strains I2,15, I7 and 18); strains exhibiting this pattern had been shown to produce a bacteriocin (Wong et al., 1981) . On repeat tests it was noticed that very occasionally there was variability in the P-type reactions of some strains in the form of apparent interconversion either between P-types 000 and 004 or between P-types 004 and 204.
Measurements were taken of the pH of the surface of the medium where the producer streak cultures had been grown. All strains that gave P-type reactions 004 and 204 gave pH readings of < 6.5 and < 6.3 respectively. All P-type 000 strains gave pH readings of > 6.5. Acid production was enhanced by growing the test strains either at an elevated temperature (37°C) or in an anaerobic atmosphere (table 11). It seemed that human strains were in general more acidogenic than animal isolates. With a supplement of glucose 0.1% (w/v) isolates produced sufficient acidic metabolites, even under the standard incubation conditions (32°C; aerobic), to inhibit indicators I2 and 17. With addition of calcium carbonate 0.5% (w/v) to the medium, none of the strains lowered the pH to 6.5, even when incubated at 37°C anaerobically. Hence on this buffered medium all of the non-bacteriocinogenic strains were of P-type 000.
The 12 bacteriocinogenic (P-type 226) human strains included three of the six isolates from patients with nephritis. When these were tested on calcium carbonatecontaining medium, all appeared to be of P-type 222, having lost their acid-mediated activity against indicator strain 17, an M-type 28 group A streptococcus. Inhibitory activity against the three remaining group-A streptococcus strains in the indicator set (12, I5 and 18) was undiminished on the buffered medium. The bacteriocinogenic strains were tested on buffered medium against 72 group A streptococci, each representing a different M serotype; only the M-type 28 prototype strain was resistant. Four of 10 other type-28 strains tested were also found to be resistant. Although all five resistant strains had 28R protein, so did four of the six bacteriocin-sensitive type-28 strains. Further evidence for the non-involvement of 28R protein in resistance was the observation that strain GT6016 (M-type 48, R28 positive) was sensitive and strain 81-265 (M-type 1, R28 negative) resistant to the inhibitor. None of 12 other M-type 1 strains was inhibitor-resistant.
None of the group-G streptococci formed acid from sorbitol or inulin, but 12 biotypes were differentiated on the basis of differences in the patterns of fermentation of lactose, salicin and trehalose, and the hydrolysis of aesculin (table 111) . Whereas all the human strains fermented trehalose only one-third of the animal strains were trehalose positive. Two-thirds of the animal strains belonged to biotypes (ALS, AS, LS, S) that were not seen among the human isolates. The 12 P-type 226 strains were of a variety of biotypes.
Fifteen different S types were recognised (table IV) ; some were found only among animal strains (e.g., 52 and 56) and others only among human strains (e.g., 77,46 and 47). The 12 P-type 226 strains gave various S-type reactions, but none of them was sensitive to group-G streptococcus strain W2580, which was P4 in the set of S-typing producer strains. Although sensitivity to strain P4 was a characteristic of 34 of the 38 non-P-type 226 human strains, only 7 of the 30 animal isolates were sensitive to P4.
DISCUSSION
When tested in the conditions of our standardised deferred-antagonism typing method, many group-G streptococci of human origin, but none of animal origin, inhibited the indicator strain 17, an M-type 28 group-A streptococcus. This effect appeared to be due to the drop in pH associated with acid production. The effect was enhanced in conditions favouring acidogenesis and eliminated on medium buffered by addition of calcium carbonate. Typing of strains on the basis of the detection of acid-mediated inhibitory effects would be critically dependent upon standardisation of the test conditions, such as the carbohydrate content of the medium, the incubation temperature and aeration. Thus, if P-types 000,004 and 204 are to have application as strain markers, all cultures should be P typed simultaneously and under carefully standardised conditions.
Twelve of the human strains of group-G streptococci produced bacteriocin-like inhibition of three group-A streptococcus strains in the indicator set, and gave acid-related inhibition of strain 17. Three of the six group-G streptococci isolated from patients with nephritis produced this substance. Other studies (Tagg, unpublished) have shown that nephritis-associated strains of group-A streptococci are more frequently bacteriocinogenic than are strains not so associated.
The inhibitors produced by the 12 P-type 226 strains had properties closely similar to those of the inhibitor produced by group-G streptococcus strain W2580 (streptococcin G-2580) (Tagg and Bannister, 1979; Wong et al., 1981) . These inhibitors are proteinaceous antibiotics with lethal action on bacteria of the same and closely related species. There is now sufficient justification for including them in the rather loosely defined group of antibiotics called bacteriocins (Tagg, Dajani and Wannamaker, 1976) .
These bacteriocins, of which streptococcin G-2580 can be considered the prototype, seem to be produced only by P-type 226 strains of group-G streptococci. In other streptococcal groups only one group-F and one group-C strain have been reported to belong to P-type 226 (Tagg and Bannister, 1979) , and the inhibitory agents produced by these strains differ from streptococcin G-2580. Group-F streptococcal strain T29 produced a heat-labile bacteriolytic enzyme of mol. wt 25 000 (Wong et al., 198 1). Group-C streptococcal strain 488 1 produced a heat-stable inhibitor; unlike the inhibitors associated with the P-type 226, group-F and group-G streptococci, its production was independent of the presence of blood in the typing medium (Schofield and Tagg, 1983) . Streptococcin G-2580 inhibits nearly all group-A streptococci. Exceptions such as the five type-28 strains and one type-1 strain reported in this study are resistant by an unknown mechanism which does not appear to be associated with the presence of the 28R protein.
Biotyping of the strains based upon the hydrolysis of aesculin and the fermentation of lactose, salicin and trehalose gave reproducible differentiation into 12 different reaction patterns. There was no apparent correlation between biotype and P type. The strains were uniform in their inability to ferment sorbitol and inulin. Our findings agree with those of Simmons and Keogh (1940) as to the biochemical characters of large-colony strains of human group-G streptococci, but we observed some differences between the biotype profiles of the human and animal strains, particularly in respect of the inability of many animal strains to ferment trehalose. Biberstein et al. (1980) in biotyping a collection of group-G streptococci of canine origin reported that 167 of 206 strains failed to produce acid from this sugar.
Labelling of the strains according to their patterns of sensitivity to six inhibitorproducing strains gave 15 S types. Some S types seemed to be specific to either human or animal strains, but this must be confirmed by the examination of larger collections of strains. All 12 P-type 226 strains were insensitive to streptococcin G-2580, giving further support to the contention that all of these strains produce specific inhibitors that are closely similar to streptococcin G-2580. The P-type 226 strains gave a variety of S-type reactions indicating that sensitivity to inhibitors is in the main independent of inhibitor production.
